NCT07686744 — Jian Lin neoantigen vaccine trial
Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma
Registry record
| Registry ID | NCT07686744 ↗ |
|---|---|
| Lead sponsor | Jian Lin |
| Collaborators | — |
| Phase | Phase 1 |
| Status | Not Yet Recruiting |
| Indication | Renal Cell Carcinoma, Advanced, Recurrent, Refractory |
| Enrollment | 8 participants (target) |
| Start date | 2026-09-01 |
| Primary completion | 2029-01-01 (est.) |
| Last registry update | 7 Jul 2026 |
Every field above is mirrored from the study record on ClinicalTrials.gov (NCT07686744), which the sponsor maintains and which carries the full protocol summary, eligibility criteria, sites and contacts. No neoantigen vaccine is approved anywhere yet — every program here is investigational, and inclusion is not an endorsement. See the methodology for how the tracker is built.
Where this fits
Daily coverage of the modality, tumor type and players this study touches:
Related trials
FAQ
What phase is NCT07686744?
NCT07686744 (Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma) is registered on ClinicalTrials.gov as Phase 1, sponsored by Jian Lin.
Is NCT07686744 recruiting?
As of the 2026-07-07 registry update, NCT07686744 is listed as "Not Yet Recruiting". Eligibility criteria, study sites and contacts are maintained by the sponsor on the ClinicalTrials.gov record.
Who is running NCT07686744?
The lead sponsor is Jian Lin.
What condition does NCT07686744 study?
The registered conditions are Renal Cell Carcinoma, Advanced, Recurrent, Refractory. Primary completion is listed as 2029-01-01 (estimated).
Are results available for NCT07686744?
neoag.ai mirrors the registry's factual fields — sponsor, phase, status and dates — and does not publish trial results. Any posted results, publications, or outcome measures appear on the ClinicalTrials.gov record for NCT07686744.
Back to the full neoantigen vaccine trial tracker — 107 studies, refreshed daily from ClinicalTrials.gov. Background: primer, glossary, and the companies landscape.